October Budget 2022-23: a no surprise budget for health

25 October 2022 - Medicines Australia welcomes tonight’s Budget which take steps towards addressing economic pressures and introduces new funding ...

Read more →

Amgen's annual trends report finds competition created by biosimilars contributed $21 billion in US health care system savings

12 October 2022 - Ninth Edition of Amgen's Biosimilar Trends Report Examines the U.S. and Global Marketplace with Biosimilars. ...

Read more →

The big squeeze?

20 July 2022 - With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both ...

Read more →

Biosimilar uptake accelerates in US—and so do the savings

13 July 2022 - Amgen's early view said health care savings from the use of these biologic therapies climbed to ...

Read more →

NHS saves 1.2 billion pounds on medicines over three years

1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for ...

Read more →

Medicare could’ve saved $3.6 billion by buying drugs at same prices as Mark Cuban’s online pharmacy, according to a new study

22 June 2022 - Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing ...

Read more →

Medicare spending on drugs with accelerated approval

24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...

Read more →

Prioritising reference products over biosimilars led to millions of missed savings for Part D

20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...

Read more →

Budget 2022-23 – no ‘big bang’ announcements in health

29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...

Read more →

Record investment in the future of Australia's health system

29 March 2022 - The Australian Government is investing in a stronger health system as part of our plan for a ...

Read more →

Final reconciliation of savings from side agreements for the full year 2021

18 March 2022 - TLV has presented the final reconciliation to the government of the outcome of the rebates in ...

Read more →

Stabilising health care’s share of the GDP

19 February 2022 - Since the 1980s, policy makers and private health insurers have implemented various interventions aimed at “bending the ...

Read more →

PBS expenditure and prescriptions report 2020-21

24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...

Read more →

Recent trends in Medicaid spending and use of drugs with US Food and Drug Administration accelerated approval

8 October 2021 - In this cross-sectional study of 216 drugs granted accelerated approval from 1992 through 2020, relative to all ...

Read more →

House report: drug companies spent more on buybacks, dividends than research

8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...

Read more →